Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum.

Lázár-Molnár E, Gácser A, Freeman GJ, Almo SC, Nathenson SG, Nosanchuk JD.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2658-63. doi: 10.1073/pnas.0711918105. Epub 2008 Feb 11.

2.

Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.

Won TJ, Jung YJ, Kwon SJ, Lee YJ, Lee DI, Min H, Park ES, Joo SS, Hwang KW.

Arch Pharm Res. 2010 Nov;33(11):1825-33. doi: 10.1007/s12272-010-1115-3. Epub 2010 Nov 30.

PMID:
21116786
3.

Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.

Bu DX, Tarrio M, Maganto-Garcia E, Stavrakis G, Tajima G, Lederer J, Jarolim P, Freeman GJ, Sharpe AH, Lichtman AH.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):1100-7. doi: 10.1161/ATVBAHA.111.224709. Epub 2011 Mar 10.

4.

Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.

Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H.

Stroke. 2011 Sep;42(9):2578-83. doi: 10.1161/STROKEAHA.111.613182. Epub 2011 Jul 7.

5.

Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.

Wang L, Han R, Hancock WW.

Eur J Immunol. 2007 Oct;37(10):2983-90.

6.

Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.

Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH.

J Clin Invest. 2007 Oct;117(10):2974-82.

7.

The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.

Raptopoulou AP, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I, Tzardi M, Klareskog L, Catrina AI, Sidiropoulos P, Boumpas DT.

Arthritis Rheum. 2010 Jul;62(7):1870-80. doi: 10.1002/art.27500.

8.

Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function.

Terawaki S, Tanaka Y, Nagakura T, Hayashi T, Shibayama S, Muroi K, Okazaki T, Mikami B, Garboczi DN, Honjo T, Minato N.

Int Immunol. 2007 Jul;19(7):881-90. Epub 2007 Jul 2.

PMID:
17606978
9.

Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway.

Lages CS, Lewkowich I, Sproles A, Wills-Karp M, Chougnet C.

Aging Cell. 2010 Oct;9(5):785-98. doi: 10.1111/j.1474-9726.2010.00611.x.

10.

Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells.

Chen L, Sham CW, Chan AM, Francisco LM, Wu Y, Mareninov S, Sharpe AH, Freeman GJ, Yang XJ, Braun J, Gordon LK.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4941-8. doi: 10.1167/iovs.09-3602. Epub 2009 May 6.

11.

Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.

Seko Y, Yagita H, Okumura K, Azuma M, Nagai R.

Cardiovasc Res. 2007 Jul 1;75(1):158-67. Epub 2007 Mar 16.

PMID:
17434153
12.

Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, Wherry EJ.

J Virol. 2010 Feb;84(4):2078-89. doi: 10.1128/JVI.01579-09. Epub 2009 Dec 2.

13.

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.

Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ.

J Exp Med. 2003 Jul 7;198(1):71-8. Erratum in: J Exp Med. 2003 Aug 18;198(4):677.

14.

CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition.

Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A.

J Immunol. 2011 Feb 1;186(3):1598-607. doi: 10.4049/jimmunol.1003304. Epub 2010 Dec 20.

15.

A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages.

Shi L, Albuquerque PC, Lazar-Molnar E, Wang X, Santambrogio L, Gácser A, Nosanchuk JD.

Eukaryot Cell. 2008 Jul;7(7):1109-17. doi: 10.1128/EC.00036-08. Epub 2008 May 16.

16.
17.

[Enhancement of antiviral immunity in HBV mouse model by blocking PD-1/PD-L1 signaling pathway].

Weng ZH, Ye P, Zhang SL.

Zhonghua Gan Zang Bing Za Zhi. 2010 Apr;18(4):263-6. doi: 10.3760/cma.j.issn.1007-3418.2010.04.007. Chinese.

PMID:
20460044
18.

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, Azuma M, Krummel MF, Bluestone JA.

Nat Immunol. 2009 Nov;10(11):1185-92. doi: 10.1038/ni.1790. Epub 2009 Sep 27.

19.

Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR.

J Immunol. 2008 Aug 15;181(4):2513-21.

20.

PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.

Keir ME, Freeman GJ, Sharpe AH.

J Immunol. 2007 Oct 15;179(8):5064-70.

Supplemental Content

Support Center